Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?-Reference-Cited by-同舟云学术

Burkholderia pseudomallei and Burkholderia mallei vaccines: Are we close to clinical trials?

Published:2017-10 Issue:44 Volume:35 Page:5981-5989
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Titball Richard W.,Burtnick Mary N.,Bancroft Gregory J.,Brett Paul

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference111 articles.

1. Structural flexibility in the Burkholderia mallei genome;Nierman;Proc Natl Acad Sci USA,2004

2. Melioidosis: a clinical overview;Limmathurotsakul;Br Med Bull,2011

3. Melioidosis;Wiersinga;N Engl J Med,2012

4. Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it;Alibek,1999

5. US biological warfare planning and preparedness: the dilemmas of policy;Moon,1999

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracking the footsteps of Burkholderia mallei: determination of the molecular differences and potential resistance genes;Turkish Journal of Medical Sciences;2024-01-01

2. Deciphering the human antibody response against Burkholderia pseudomallei during melioidosis using a comprehensive immunoproteome approach;Frontiers in Immunology;2023-12-11

3. Detection of low-level animal-to-animal transmission in BALB/c mouse models of melioidosis;Frontiers in Bacteriology;2023-11-06

4. Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, Thailand;Wellcome Open Research;2023-09-19

5. Assessment of CD200R Activation in Combination with Doxycycline in a Model of Melioidosis;Microbiology Spectrum;2023-06-15